Celesio

Last updated

McKesson Europe AG
Subsidiary
ISIN DE000CLS1001  OOjs UI icon edit-ltr-progressive.svg
Industry Pharmaceuticals
Founded1835
FounderFranz Ludwig Gehe
Headquarters Stuttgart, Germany
Key people
  • Kevin Kettler (Chairman of the Management Board/ Chief Operating Officer/ Labour Relations Director),
  • Brian S. Tyler (Chairman of the Supervisory Board)
Servicespharmaceutical wholesale and retail
Revenue€21.18 billion (FY 2019) [1]
Number of employees
36,917 (FY 2019)
Parent McKesson Corporation (76%)
Website www.mckesson.eu

McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%. The remaining 22.99% of shares are in free float. Kevin Kettler, a US citizen, has been Chairman of McKesson Europe since 1 November 2018. [2]

Contents

Overview

The head office is situated at Stockholmer Platz in the new Europaviertel of Stuttgart, next to Stadtbibliothek and Milaneo shopping centre. The company's core business consists of pharmaceutical wholesale and pharmacies. In the pharmaceutical wholesaling sector, Celesio has a market presence in 14 countries. It has a range of services for pharmacists on matters of health, medicines and wellness. An extensive distribution network of more than 134 branches provides deliveries to some 65,000 pharmacies and hospitals.[ citation needed ]

Company structure

The business is divided into two business areas:

History

1835 - 1948

The chemist and paint business Gehe & Co. was founded on 1 May 1835 by Franz Ludwig Gehe in Dresden on Königstraße and opened to the capital market by converting it into a stock corporation on 1 January 1903. In January 1904, the shares were admitted to trading on the stock exchange in Dresden.

In 1909, the company moved to the new location on Leipziger Straße and the trading house in Königstraße was vacated. With capital increases in 1910 and 1912, the financial basis for the establishment and expansion of a German-wide distribution of "drugs and paints, pharmaceutical and chemical products" was created. In 1922, the company founded its first German branch in Stuttgart. After the Second World War, the parent company in Dresden and most of the branches were expropriated. Gehe & Co. AG made a fresh start in West Germany with branches in Stuttgart, Kassel and Sulzbach-Rosenberg.

1948 - 1981

The Gehe parent company continued to operate in 1947 in Dresden under the name Heilchemie as a publicly owned enterprise and on 1 April 1951 with the nationalised parent company of the pharmaceutical company Dr. Madaus & Co. from Radebeul merged to form VEB Arzneimittelwerk Dresden. Haniel took over the majority of the Gehe & Co. AG shares with effect from 1 January 1973. The condition of Haniel was that the GEHE’s management remained in the company, in order to further expand the solid foundation that was established after the war. The name Gehe, known in the pre-war period, was brought to the attention of pharmacists with the revitalised or newly created branches. These branches were formed during the transition to Haniel: Bremen, Hamburg, Kassel, Kelkheim, Landshut, Mühldorf, Munich, Nuremberg, Regensburg and Stuttgart. In 1973, the company achieved a turnover of DM 285 million. Other pharmaceutical wholesalers (Friedrich Schäfer GmbH, Weiterstadt and Kaiserslautern, Wilmaco GmbH, Hamm and Lieser Pharma-GmbH, Duisburg) were brought in to Gehe & Co. AG via the majority shareholder Franz Haniel & Cie.

1981 - 2008

In 1982, the Haniel Group acquired RUWA Rudloff & Watermann GmbH & Co. KG in Minden, a pharmaceutical wholesale company with a branch in Delmenhorst and integrated it into Gehe. In 1985, the Kaiser + Kraft Group, Stuttgart, a mail-order business for transport, storage, operational facilities and office equipment, was acquired. Until 1992, customers in Germany were supplied from the branches based in Hamburg, Berlin, Haan, Dresden, Stuttgart and Munich. In the following years, the group's trading structure spread across 14 countries in Europe and the USA. With the public offering of TAKKT on 15 September 1999, the spin-off of the Mail Order Division was ended.

From 2003

In April 2003, the company celebrated its 100th year. On the birthday of the conversion into a joint-stock company, the Annual General Meeting decided to change the name from Gehe AG to Celesio AG, with a majority of 99.98%. Today, the German subsidiary GEHE Pharma Handel still operates under its original name. In April 2007, Celesio announced the acquisition of 90% of the shares in the mail-order pharmacy DocMorris, in order to build up a pharmacy chain across Germany. The acquisition took place in hopes that the third-party ownership ban of the Pharmacies Act would fail, but it was legitimised in May 2009 by the EuGH. For the pharmaceutical wholesaler Gehe, which was also part of the Celesio Group, the acquisition resulted in a loss of customers as pharmacists saw a threat in the chain. DocMorris was now operated as a franchise-like concept, in which pharmacists were allowed to use the DocMorris brand with the payment of a monthly licence fee. As a result, Celesio sold DocMorris in October 2012 to the company Zur Rose AG.

In June 2009, it became known that Celesio had acquired the majority of the largest Brazilian pharmaceutical wholesaler, Panpharma. In April 2012, Panpharma was fully taken over. In February 2016, Celesio agreed to sell its Brazilian business, consisting of Panpharma and Oncoprod, to the holding of the Brazilian pharmaceutical wholesaler, SantaCruz. In September 2013, Celesio sold its subsidiary, Rudolf Spiegel GmbH, to the company WEPA Apothekenbedarf.

On 24 October 2013, the US-based McKesson Corporation announced an agreement to acquire Celesio for EUR 6.1 billion (approx. EUR 23 per share). However, on 13 January 2014, the company reported that McKesson's acquisition of Celesio was unsuccessful, due to the 75% threshold not being reached. At the start of November 2013, the Elliot hedge fund acquired 12.68% of Celesio from Paul Singer, a well-known course of action by him to benefit from takeovers. Following McKesson's failed takeover, Singer increased his direct and indirect stake to around 32%. On 23 January 2014, Haniel took over the share from the Elliott hedge fund and served the 75.99% one day later to McKesson, which meant that the takeover was still a success. Sainsbury’s and Celesio announced the formation of a strategic pharmacy partnership in July 2013, in the course of which McKesson Europe's subsidiary LloydsPharmacy would acquire Sainsbury’s pharmacy business for GBP 125 million. Until 21 September 2015, the company's shares were listed in MDAX. The quotation in the index was removed, due to the change in the stock exchange segment from Prime Standard to the Regulated Unofficial Market. On 12 September 2017, Celesio was renamed McKesson Europe.

On 12 December 2019, McKesson Corporation announced that it planned to bring its German wholesale business (GEHE Pharma Handel GmbH, a subsidiary of McKesson Europe) into a joint venture with Alliance Healthcare Deutschland AG (a subsidiary of Walgreens Boots Alliance). McKesson should hold 30% of the planned joint venture, Walgreens Boots Alliance 70%.

Management Board

Supervisory Board

See also

Related Research Articles

Alliance Healthcare organization

Alliance Healthcare, formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in December 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on July 31, 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company had revenues of $208.4 billion in 2018.

Cardinal Health company

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Its headquarters are based in Dublin, Ohio and Dublin, Ireland (EMEA). The company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical products, including gloves, surgical apparel, and fluid management products. In addition, it operates the largest network of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.

Schering AG company

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Alliance Boots company

Alliance Boots GmbH was a multinational pharmacy-led health and beauty group with corporate headquarters in Bern, Switzerland and operational headquarters in Nottingham and Weybridge, United Kingdom.

LloydsPharmacy is a British pharmacy company, with more than 1,500 pharmacies. It has around 17,000 staff and dispenses over 150 million prescription items annually. It is owned by the German company Celesio, formerly GEHE AG, which is in turn owned by the American McKesson Corporation.

PHOENIX Pharmahandel Aktiengesellschaft & Co KG, headquartered in Mannheim, Baden-Württemberg, is the largest pharmaceutical wholesaler in Germany, and the second largest in Europe with about 153 distribution centers across the country delivering drugs to some 12,000 independent pharmacies. Its PHOENIX Documentation is an Internet-based archive offering detailed information on drugs, their components, indications, and effects. Formation of Holding company PHOENIX International Beteiligungs GmbH. Phoenix Group is majority owner of the pharmaceutical wholesalers Purus A.S. in the Czech Republic and Tamro in Finland. Phoenix Group itself is majority-owned by pharmaceutical conglomerate Merckle Group.

Australian Pharmaceutical Industries (API) is a health and beauty company in Australia that is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. The company is involved in retailing through company-owned stores and franchise operations. API is listed on the Australian Securities Exchange and operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice.

Norsk Medisinaldepot Norwegian pharmaceutics wholesaler

Norsk Medisinaldepot AS is a pharmaceutics and healthcare products wholesaler in Norway. It also operates the pharmacy chains Vitusapotek and the franchise chain Ditt Apotek. NMD is part of the Celesio group and has a total of 185 pharmacies in Norway. The company is based in Oslo.

Pharmacies of Norway are dominated by the three large companies Alliance Boots, Apokjeden and Norsk Medisinaldepot. In total there are 606 pharmacies, of which only 16 do not belong to the four dominant chains Apotek 1, Vitusapotek, Boots apotek and Ditt Apotek. 33 pharmacies are state owned as pharmaceutical trusts.

Stada Arzneimittel German pharmaceutical company

Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes in the production of generic and over-the-counter drugs. In 2018, revenue totaled €2.33 billion.

Jenapharm

Jenapharm is a pharmaceutical company from Jena, Germany. Founded in 1950 in East Germany, the company focused from the beginning on the production and development of steroids. Due to the economic circumstances of the Eastern Bloc, the company initially used a unique process of steroid synthesis starting from hog bile, however this method was abandoned a decade later in favor of total synthesis. Initially the company produced a wide range of generic steroids, including corticosteroids, but later on it focused on anabolic steroids, estrogens and progestins.

Ulf Mark Schneider businessperson

Ulf Mark Schneider is a German/American businessman, and the CEO of Nestlé. He is the former CEO of Fresenius, a €28 billion global healthcare group.

Evotec company

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of September 2018, Evotec had a market capitalization of €3.29 billion and a pipeline of more than 100 partnered programs in discovery, pre-clinical development and clinical development.

AAH Pharmaceuticals Pharmaceutical wholesaler of the United Kingdom

AAH is a pharmaceutical wholesaler in the United Kingdom. Originally formed in 1892 as a company selling solid fuels in South Wales, it was floated on the stock exchange in 1923. It diversified into pharmaceuticals in the 1970s, and since 1995 it has been a subsidiary of the German company Celesio AG.

Franz Haniel & Cie. GmbH is a German family-owned investment holding company headquartered in Duisburg, Germany. Haniel was founded in 1756 in the city of Ruhrort, now Duisburg. Today the company is one of Europe's largest privately owned family businesses. The Haniel family consists of more than 600 family members and is considered as one of the wealthiest families in Germany.

Allen John Lloyd is the founder of LloydsPharmacy, a British pharmacy company, with more than 1,600 pharmacies, and around 17,000 staff.

Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange.

Wörwag Pharma German pharmaceutical company

Wörwag Pharma is an independent family-owned pharmaceutical company headquartered in Böblingen, Germany. It was founded in 1971 by Fritz Wörwag, a pharmacist. It sells prescription and over-the-counter preparations as well as food supplements.

References

  1. ↑ "McKesson Company Profile". craft.co. Retrieved 8 October 2019.
  2. ↑ "McKesson and Celesio to operate as an integrated company – achieving important acquisition milestone". www.mckesson.eu. Retrieved 27 July 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.